Yablonka Uri 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Nov 13, 2017
Insider Transaction Report
Form 4
Yablonka Uri
DirectorChief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2017-11-10+13,333→ 13,333 totalExercise: $0.75From: 2017-12-10Exp: 2027-11-10→ Common Stock (13,333 underlying)
Footnotes (1)
- [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on December 10, 2017 until fully vested and exercisable on November 10, 2018, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.